The effect of catheter-directed thrombolytic use on readmission rates and in-hospital outcomes among cancer patients with venous thromboembolism in the United States

Avirup Guha; Grant McKinley; Amit K. Dey; Rebecca Carter; P. Elliott Miller; Abhishek J. Deshmukh; Raja Zaghlol; Ana Barac; Nihar R. Desai; Daniel Addison

doi:10.1111/jocs.14444

The effect of catheter-directed thrombolytic use on readmission rates and in-hospital outcomes among cancer patients with venous thromboembolism in the United States

Avirup Guha
, Grant McKinley
, Amit K. Dey
, Rebecca Carter
, P. Elliott Miller
, Abhishek J. Deshmukh
, Raja Zaghlol
, Ana Barac
, Nihar R. Desai
, Daniel Addison

Cardiology

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

Background: Cancer inducing a hypercoagulable state, venous thromboembolism (VTE) remains a leading cause of morbidity and mortality globally. We assessed the impacts of cancer on the likelihood for readmission after a VTE-targeted procedure. Methods: We created a new cohort using discharge-level data from all hospitalizations from State Inpatient Databases of geographically dispersed participating states (18-27 states). Results: In those presenting with VTE during index-admission (619 241), 2.4% patients underwent catheter directed thrombolytic therapy (CDL) on index admission and among those 20.3% had cancer. Moreover, the 30-day readmission rate amongst CDL recipients (10 776 overall) was 14.3% in those with cancer compared to 8.8% in those with no cancer history (P

Original language	English (US)
Pages (from-to)	609-611
Number of pages	3
Journal	Journal of Cardiac Surgery
Volume	35
Issue number	3
DOIs	https://doi.org/10.1111/jocs.14444
State	Published - Mar 1 2020

Keywords

cancer
catheter directed thrombolytic
cost of care
readmission
venous thromboembolism

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/jocs.14444

Cite this

Guha, A., McKinley, G., Dey, A. K., Carter, R., Miller, P. E., Deshmukh, A. J., Zaghlol, R., Barac, A., Desai, N. R., & Addison, D. (2020). The effect of catheter-directed thrombolytic use on readmission rates and in-hospital outcomes among cancer patients with venous thromboembolism in the United States. Journal of Cardiac Surgery, 35(3), 609-611. https://doi.org/10.1111/jocs.14444

Guha, A, McKinley, G, Dey, AK, Carter, R, Miller, PE, Deshmukh, AJ, Zaghlol, R, Barac, A, Desai, NR & Addison, D 2020, 'The effect of catheter-directed thrombolytic use on readmission rates and in-hospital outcomes among cancer patients with venous thromboembolism in the United States', Journal of Cardiac Surgery, vol. 35, no. 3, pp. 609-611. https://doi.org/10.1111/jocs.14444

@article{0a6b72f5d8ab49d8800db86b5b568796,

title = "The effect of catheter-directed thrombolytic use on readmission rates and in-hospital outcomes among cancer patients with venous thromboembolism in the United States",

abstract = "Background: Cancer inducing a hypercoagulable state, venous thromboembolism (VTE) remains a leading cause of morbidity and mortality globally. We assessed the impacts of cancer on the likelihood for readmission after a VTE-targeted procedure. Methods: We created a new cohort using discharge-level data from all hospitalizations from State Inpatient Databases of geographically dispersed participating states (18-27 states). Results: In those presenting with VTE during index-admission (619 241), 2.4\% patients underwent catheter directed thrombolytic therapy (CDL) on index admission and among those 20.3\% had cancer. Moreover, the 30-day readmission rate amongst CDL recipients (10 776 overall) was 14.3\% in those with cancer compared to 8.8\% in those with no cancer history (P ",

keywords = "cancer, catheter directed thrombolytic, cost of care, readmission, venous thromboembolism",

author = "Avirup Guha and Grant McKinley and Dey, \{Amit K.\} and Rebecca Carter and Miller, \{P. Elliott\} and Deshmukh, \{Abhishek J.\} and Raja Zaghlol and Ana Barac and Desai, \{Nihar R.\} and Daniel Addison",

year = "2020",

month = mar,

day = "1",

doi = "10.1111/jocs.14444",

language = "English (US)",

volume = "35",

pages = "609--611",

journal = "Journal of Cardiac Surgery",

issn = "0886-0440",

publisher = "John Wiley and Sons Inc.",

number = "3",

}

TY - JOUR

T1 - The effect of catheter-directed thrombolytic use on readmission rates and in-hospital outcomes among cancer patients with venous thromboembolism in the United States

AU - Guha, Avirup

AU - McKinley, Grant

AU - Dey, Amit K.

AU - Carter, Rebecca

AU - Miller, P. Elliott

AU - Deshmukh, Abhishek J.

AU - Zaghlol, Raja

AU - Barac, Ana

AU - Desai, Nihar R.

AU - Addison, Daniel

PY - 2020/3/1

Y1 - 2020/3/1

N2 - Background: Cancer inducing a hypercoagulable state, venous thromboembolism (VTE) remains a leading cause of morbidity and mortality globally. We assessed the impacts of cancer on the likelihood for readmission after a VTE-targeted procedure. Methods: We created a new cohort using discharge-level data from all hospitalizations from State Inpatient Databases of geographically dispersed participating states (18-27 states). Results: In those presenting with VTE during index-admission (619 241), 2.4% patients underwent catheter directed thrombolytic therapy (CDL) on index admission and among those 20.3% had cancer. Moreover, the 30-day readmission rate amongst CDL recipients (10 776 overall) was 14.3% in those with cancer compared to 8.8% in those with no cancer history (P

AB - Background: Cancer inducing a hypercoagulable state, venous thromboembolism (VTE) remains a leading cause of morbidity and mortality globally. We assessed the impacts of cancer on the likelihood for readmission after a VTE-targeted procedure. Methods: We created a new cohort using discharge-level data from all hospitalizations from State Inpatient Databases of geographically dispersed participating states (18-27 states). Results: In those presenting with VTE during index-admission (619 241), 2.4% patients underwent catheter directed thrombolytic therapy (CDL) on index admission and among those 20.3% had cancer. Moreover, the 30-day readmission rate amongst CDL recipients (10 776 overall) was 14.3% in those with cancer compared to 8.8% in those with no cancer history (P

KW - cancer

KW - catheter directed thrombolytic

KW - cost of care

KW - readmission

KW - venous thromboembolism

UR - https://www.mendeley.com/catalogue/a587a742-9d11-3ad7-8092-e71c6af7bdf7/

U2 - 10.1111/jocs.14444

DO - 10.1111/jocs.14444

M3 - Article

C2 - 32017181

SN - 0886-0440

VL - 35

SP - 609

EP - 611

JO - Journal of Cardiac Surgery

JF - Journal of Cardiac Surgery

IS - 3

ER -

The effect of catheter-directed thrombolytic use on readmission rates and in-hospital outcomes among cancer patients with venous thromboembolism in the United States

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this